Showing results (1181-1190 of 1,412) with videos related to

Sort By:
Pageof 142
NPJ Parkinson'S Disease|April 15, 2023
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson's diseaseMartín Martínez, Mikel Ariz, Ignacio Alvarez, et al.
NPJ Parkinson'S Disease|May 11, 2023
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's diseaseCheryl E G Leyns, Alice Prigent, Brenna Beezhold, et al.
NPJ Parkinson'S Disease|July 16, 2020
Altered interhemispheric synchrony in Parkinson's disease patients with levodopa-induced dyskinesiasCaiting Gan, Min Wang, Qianqian Si, et al.
NPJ Parkinson'S Disease|April 13, 2021
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factorKathryn M Miller, Natosha M Mercado, Caryl E Sortwell
NPJ Parkinson'S Disease|July 14, 2020
Long-term Parkinson's disease quality of life after staged DBS: STN vs GPi and first vs second leadStephanie Cernera, Robert S Eisinger, Joshua K Wong, et al.
NPJ Parkinson'S Disease|April 10, 2023
Association between smoking and all-cause mortality in Parkinson's diseaseSeo Yeon Yoon, You Hyun Park, Sang Chul Lee, et al.
NPJ Parkinson'S Disease|April 26, 2023
Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysisMakoto Hattori, Keita Hiraga, Yuki Satake, et al.
NPJ Parkinson'S Disease|October 2, 2022
From anticipation to impulsivity in Parkinson's diseaseBertrand Degos, Pierre Pouget, Marcus Missal
NPJ Parkinson'S Disease|October 6, 2022
Cathepsin L-containing exosomes from α-synuclein-activated microglia induce neurotoxicity through the P2X7 receptorTianfang Jiang, Chuanying Xu, Shane Gao, et al.
NPJ Parkinson'S Disease|September 15, 2022
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seedingIsabel Wurster, Corinne Quadalti, Marcello Rossi, et al.
Pageof 142